Skip to main content
. 2018 Aug 7;32(5):1555–1563. doi: 10.1111/jvim.15240

Figure 1.

Figure 1

Urinary aldosterone to creatinine ratio percent change from day 0 to day 30 in both groups. Asterisk (*) denotes statistical significance in S/V group compared with placebo, P = .032. UAldo : C: urinary aldosterone to creatinine ratio, S/V: sacubitril/valsartan